Our national lupus research program aggressively seeks to advance the science and medicine of lupus and to improve the quality of life for all people affected by lupus.
New Therapeutic Targets for Lupus
Dr. David Isenberg, Academic Director for Rheumatology at University College London reports that the field of lupus is changing as several new therapies are on the horizon and researchers are identifying new ways to manage the disease. In this video, Dr. Isenberg discusses several of the new agents under evaluation and looks to ways lupus treatment will change with evolving technology and new scientific findings, which are presenting new pathways for stopping the disease from causing damage to the body.
The Lupus Foundation of America Corporate Advisory Council provides industry perspective helping identify and address barriers to lupus drug development.